DFDA

Supervised Exercise Therapy (SET)

Treatment for Lower Extremity Peripheral Arterial Disease

Typical Dosage: 30-60 minutes, 3 times per week

Effectiveness
75%
Safety Score
95%
Clinical Trials
150
Participants
15K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
30-60 minutes, 3 times per week
Time to Effect
3-6 months
Treatment Duration
Ongoing (typically 3-6 months structured program, then maintenance)
Evidence Quality
HIGH
Number Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$0
Total Annual:$500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$8,000/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$2,857
Cost per Remission
$4,000
Supervised Exercise Therapy (SET) Outcomes

for Lower Extremity Peripheral Arterial Disease

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+70%
Remission Rate
+50%
Common Side Effects
Muscle soreness
+30%
Fatigue
+20%
Minor musculoskeletal injury
+5%

Sources:

vascular-medicine.org
psu.edu
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov